Skip to main content

Journey Medical Corporation (DERM)

NASDAQ: DERM · IEX Real-Time Price · USD
6.75 0.00 (0.00%)
Dec 3, 2021 4:00 PM EST - Market closed
Market Cap110.98M
Revenue (ttm)49.18M
Net Income (ttm)-9.07M
Shares Out16.44M
EPS (ttm)-0.55
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,863
Open6.75
Previous Close6.75
Day's Range6.75 - 6.98
52-Week Range6.00 - 10.20
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About DERM

Journey Medical Corporation is a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Our current portfolio includes five branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the U.S. Journey Medical is managed and led by experienced life science executives with a track record of creating value for their stakeholders and bringing novel medicines to the market, enabling patients...

IndustryPharmaceuticals
IPO DateNov 12, 2021
CEOClaude Maraoui
Employees82
Stock ExchangeNASDAQ
Ticker SymbolDERM
Full Company Profile

Financial Performance

In 2020, DERM's revenue was $44.53 million, an increase of 27.52% compared to the previous year's $34.92 million. Earnings were $5.28 million, an increase of 45.74%.

Financial Statements

News

Journey Medical Corporation Announces Closing of Initial Public Offering

SCOTTSDALE, Ariz., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that focuses on the development and commerc...

Other symbols:FBIO
2 weeks ago - GlobeNewsWire

Journey Medical Corporation Prices $35.2 Million Initial Public Offering

Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”), a commercial-stage pharmaceutical...

3 weeks ago - GlobeNewswire

Journey Medical Corporation Announces Launch of its Initial Public Offering

Journey Medical Corporation (“Journey Medical”), a commercial-stage pharmaceutical company that...

3 weeks ago - GlobeNewswire

Dermatological drug maker Journey Medical files for a $40 million IPO

Journey Medical, a commercial-stage pharma with a portfolio of dermatological drugs, filed on Friday with the SEC to raise up to $40 million in an initial public offering.

1 month ago - Renaissance Capital

Journey Medical IPO Registration Document (S-1)

Journey Medical Corporation has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC